Switzerland-based Roche is today stepping up the crisis in Ukraine with plans to donate 150,000 packets of Rocephin, an essential antibiotic used to treat bacterial infections, to beleaguered citizens.
The pharmaceutical major – which has been deliberately silent on its personnel support operations in Ukraine – has outlined plans to work with ‘external partners’ to get antibiotics into the war-torn country, which is not an easy proposition as Russian troops maintain a constant barrage on Ukraine’s biggest cities. And he plans to follow up with more contributions as he works to see what is needed and how he can help.
Roche is not alone among the biopharma crowd seeking to support Ukraine’s embattled defenders.
Prague-based Zentiva said it plans to deliver 100,000 drug packs covering drug therapies, cardiovascular drugs, painkillers and anti-infectives.
Zentiva executives plan to continue working on this as they find themselves in the same boat as more drug actors around the world keen to support staff members working in the healthcare sector by Ukraine. Bayer yesterday noted its work in providing hard-to-find cash and housing for its 700 employees.
Others have taken action this week, including the industry association Medicines for Europe, GlaxoSmithKline is working with NGOs and Boehringer Ingelheim is contributing €2.5 million to humanitarian aid funds. Merck KGaA and Novo Nordisk Foundation are also contributing money and more will likely follow.
We will keep a regular tally of contributions from pharmaceutical companies for Ukraine here at Terminal Newsso please send us alerts about new offers as they appear.